Drug-induced lung disease is a classic “USMLE trap” because the stem often looks like infection, CHF, PE, or autoimmune ILD—and the answer choices are usually built to punish sloppy pattern recognition. The key is to anchor on timing, exposure, imaging pattern, and a few buzzword toxicities, then rapidly eliminate distractors with 1–2 decisive findings.
The Vignette (Q-bank style)
A 67-year-old man with atrial fibrillation and heart failure presents with 3 months of progressive dyspnea on exertion and dry cough. He denies fever, chills, chest pain, wheezing, or leg swelling. Medications include amiodarone, lisinopril, furosemide, and apixaban. He has never smoked.
Vitals: T 37.0°C, BP 128/76, HR 62, RR 18, O sat 90% on room air. Lungs: fine end-inspiratory crackles bilaterally. No JVD, no peripheral edema.
CXR shows bilateral interstitial opacities. HRCT shows diffuse ground-glass opacities with reticular changes, greatest at the bases. PFTs reveal: ↓ TLC, ↓ FVC, normal/↑ FEV1/FVC, and ↓ DLCO.
Question: Which is the most likely cause of his lung disease?
Answer choices:
A. Amiodarone toxicity
B. Idiopathic pulmonary fibrosis
C. Cardiogenic pulmonary edema from left-sided heart failure
D. Pneumocystis jirovecii pneumonia
E. Pulmonary embolism
F. Chronic obstructive pulmonary disease
Step-by-Step: Why the Correct Answer Is Correct (A. Amiodarone toxicity)
This is restrictive + interstitial pattern + exposure with the right timeline.
Why amiodarone fits best
- Medication risk: Amiodarone is high-yield for drug-induced interstitial lung disease (ILD).
- Time course: Often subacute to chronic (weeks to months; can be longer).
- Symptoms: Progressive dyspnea + dry cough (fever may or may not be present).
- Exam: Fine “Velcro” crackles can mimic IPF.
- PFTs: Restriction (↓ TLC) + ↓ DLCO (very common in ILD).
- Imaging: HRCT often shows ground-glass opacities, interstitial infiltrates, and sometimes fibrosis. (Amiodarone can also cause organizing pneumonia patterns.)
High-yield mechanistic pearl
- Amiodarone is iodine-rich and lipophilic → accumulates in tissues (lung, liver, skin).
- Lung injury can be direct cytotoxicity and/or hypersensitivity.
Next best step (often asked)
- Stop amiodarone
- Consider systemic glucocorticoids for significant or progressive disease
- Supportive care (oxygen), and evaluate severity
The “Why Every Answer Choice Matters” Breakdown (Distractors)
Below is how to systematically kill each distractor using 1–2 differentiators—exactly what you need under time pressure.
B. Idiopathic pulmonary fibrosis (IPF)
Why it tempts you:
- Age > 60, dry cough, crackles, restrictive PFTs, ↓ DLCO—sounds like IPF.
Why it’s wrong here:
- The stem gives a major alternative cause: amiodarone, which is a classic ILD trigger.
- IPF classically shows UIP pattern on HRCT:
- Subpleural, basilar-predominant reticulation
- Honeycombing ± traction bronchiectasis
- This vignette emphasizes diffuse ground-glass + reticular change rather than honeycombing/UIP.
USMLE anchor:
- IPF = UIP = honeycombing (think “irreversible scarred lung with honeycomb cysts”).
C. Cardiogenic pulmonary edema from left-sided heart failure
Why it tempts you:
- He has heart failure; dyspnea; bilateral opacities.
Why it’s wrong here:
- CHF pulmonary edema is typically acute or episodic, not a slow 3-month progressive course (unless severely uncontrolled).
- You’d expect orthopnea, PND, JVD, S3, edema, weight gain, or elevated BNP.
- Imaging of cardiogenic edema often shows:
- Kerley B lines, cardiomegaly, perihilar “bat-wing” pattern, pleural effusions
- PFTs in pure CHF aren’t classically a restrictive ILD pattern with prominent ↓ DLCO as the key.
USMLE anchor:
- Edema is a “wet” story: orthopnea/PND + volume overload signs + cardiomegaly/effusions.
D. Pneumocystis jirovecii pneumonia (PJP)
Why it tempts you:
- Ground-glass opacities on CT are a hallmark.
Why it’s wrong here:
- PJP is most likely in HIV/AIDS (CD4 < 200), transplant, chronic steroids, chemotherapy.
- Usually presents with:
- Fever, tachypnea, hypoxemia (often more dramatic)
- Subacute course (days–weeks), not typically a quiet 3-month progression without systemic symptoms
- The stem gives no immunosuppression history.
USMLE anchor:
- PJP = immunocompromised + fever + hypoxemia + diffuse GGOs; treat with TMP-SMX (± steroids if severe).
E. Pulmonary embolism (PE)
Why it tempts you:
- Dyspnea and hypoxemia.
Why it’s wrong here:
- PE is acute (minutes–days), not a 3-month progressive restrictive lung disease.
- CT findings in ILD (ground-glass + reticulation) don’t match PE.
- PFTs in PE do not typically show a classic restrictive pattern; you might see:
- Increased dead space, V/Q mismatch; sometimes low DLCO can be seen, but not with this imaging story.
- Also, he’s on apixaban, lowering (not eliminating) PE probability.
USMLE anchor:
- PE = sudden dyspnea/pleuritic chest pain ± hemoptysis; think V/Q mismatch, not fibrosis.
F. Chronic obstructive pulmonary disease (COPD)
Why it tempts you:
- Older patient with dyspnea.
Why it’s wrong here:
- He’s a never-smoker (not impossible, but less likely).
- COPD is obstructive:
- ↓ FEV1/FVC
- Often ↑ TLC (air trapping) rather than ↓ TLC
- CT would show emphysema (hyperlucency, bullae), not interstitial reticulation/ground-glass.
USMLE anchor:
- COPD = obstruction + hyperinflation (↑ TLC, barrel chest, decreased breath sounds, wheeze).
Quick Pattern-Recognition Table: Restrictive/Interstitial vs Common Mimics
| Condition | Time course | Key risk factor/clue | HRCT/CXR clue | PFT pattern |
|---|---|---|---|---|
| Drug-induced ILD (amiodarone) | Weeks–months | Amiodarone (also nitrofurantoin, bleomycin, etc.) | GGOs ± reticulation/fibrosis | Restrictive + ↓ DLCO |
| IPF (UIP) | Months–years | Older age, no clear trigger | Basilar subpleural reticulation + honeycombing | Restrictive + ↓ DLCO |
| CHF pulmonary edema | Acute/subacute | Volume overload signs | Cardiomegaly, effusions, bat-wing | Variable; not classic ILD |
| PJP | Days–weeks | Immunosuppression | Diffuse GGOs | Often ↓ DLCO, but clinical context rules |
| PE | Acute | DVT risks, pleuritic CP | Often normal CXR | Not a restrictive ILD picture |
| COPD | Years | Smoking | Hyperinflation, emphysema | Obstructive, ↑ TLC |
High-Yield Drug Causes of Interstitial Lung Disease (Memorize These)
Common Step-worthy offenders
- Amiodarone → ILD/pneumonitis, fibrosis (plus thyroid, liver, corneal deposits, blue-gray skin)
- Nitrofurantoin → acute hypersensitivity pneumonitis or chronic ILD (esp. long-term prophylaxis)
- Bleomycin → pulmonary fibrosis (risk increases with high FiO exposure)
- Methotrexate → pneumonitis/ILD
- Busulfan, cyclophosphamide → fibrosis (less commonly tested than bleomycin)
- Checkpoint inhibitors (e.g., nivolumab, pembrolizumab) → pneumonitis (increasingly relevant clinically)
Exam tip: When the stem screams “ILD” and includes a medication list, the medication is often the diagnosis.
How to Answer These Under Timed Conditions (3-Step Elimination)
- Confirm ILD physiology: Restriction (↓ TLC) + ↓ DLCO + crackles + interstitial imaging.
- Scan for a trigger: meds (amiodarone, nitrofurantoin, bleomycin), radiation, occupational exposures, connective tissue disease.
- Match imaging pattern + timeline:
- Honeycombing/UIP → IPF
- Bat-wing + volume signs → CHF
- Diffuse GGO + immunosuppression + fever → PJP
- Sudden dyspnea + pleuritic CP → PE
Take-Home Points (What You Should Remember on Test Day)
- Amiodarone is a top-tier cause of drug-induced ILD → progressive dyspnea, dry cough, crackles, restrictive PFTs with ↓ DLCO, interstitial changes on imaging.
- IPF = UIP = honeycombing (subpleural basilar fibrosis).
- CHF edema has a “wet,” volume-overload story and classic radiographic clues (cardiomegaly/effusions).
- PJP requires immunosuppression; GGO alone is not enough.
- PE is acute; COPD is obstructive and typically hyperinflated.